GMI

Lycopene and soy isoflavones have activity in prostate cancer patients with PSA relapse disease and may delay progression of both hormone-refractory and hormone-sensitive prostate cancer.


Comments

Leave a Reply

Your email address will not be published. Required fields are marked *